Add GPA to the list of causes of dacryoadenitis (inflammation of the lacrimal gland, main or accessory). Differential diagnoses of dacryoadenitis: ● Sjogren's ● Sarcoidosis ● IgG4 RD ● AL Amyloidosis ● GPA John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/dvXbkpfcAq

After an incredible 2.5 years for the COVID-19 GRA @rheum_covid, @philipcrobinson addresses the celebration of all that’s been achieved at #ACR22 - followed by @JYazdanyMD @pedrommcmachado @rheum_cat and more Congratulations to all who have been involved! @RheumNow https://t.co/jO5c6yRI6F

Learn the terms used by the ophthalmologists: ◦ KP ◦ PUK ◦ IOI ➢ PUK is a medical emergency ➣ Think RA, AAV in PUK John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/yVGRpjrijN

This quality improvement proj by Dr Gennaoui et al assessed MD compliance in HCQ eye screening 👇 After an educ intervention, 👀 specialist documentation available ☑️significantly MD doc & uptodate screening also ⬆️not sig(p>0.05) Screen pts on HCQ. #ACR22 @RheumNow ABST#0346 https://t.co/IPAxXsp3Lu

@RheumNow video discussing Ab0374: Can you use BASDAI in pregnancy? https://t.co/yreu38VwdE #ACR22 https://t.co/g3nxfhSlOJ

• Can you use the BASDAI in Pregnancy? - YouTube
• https://twitter.com/ericdeinmd/status/1591513811307175941

Doppelgängers are double walkers with similar features. GPA and IgG-RD are doppelgängers. 3 findings in GPA that are not found in IgG4-RD: ◦ Granulomatous inflammation ◦ Necrosis ◦ Neutrophilic infiltration John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/F67EhGBcS4

Hear what KOLs are saying about #ACR22. We are featuring Drs: Michele Petri, Peter Nash, Artie Kavanaugh, Jack Cush. Follow us on Twitter and head to https://t.co/V10S4oVFsv! https://t.co/uRZLffesrq

• http://RheumNow.com

Delighted to have caught up with ⁦@SattuiSEMD⁩ to discuss his Abst #0444- Frailty and it’s associated factors in vasculitis #ACR22 ⁦@RheumNow⁩ https://t.co/r2740kuQET

• Frailty in Vasculitis - YouTube

Treating the underlying CTD is key to managing ILD in combination with anti-fibrotic. In the SENCIS study, patients on combination of MMF at baseline +Nintedanib had reduced decline in FVC compared to Nintedanib alone https://t.co/NmVRZ44JGE Paul Noble #ACR22 @RheumNow https://t.co/mulaBK61ga

• http://bit.ly/3tsDK5W

Join us for our daily topic panels--we'll be live on Twitter, LinkedIn, FB and YouTube OR sign up directly below. https://t.co/lZK8vsySiD https://t.co/smUveqf3C6

• https://bit.ly/3E5R84U